The Prolific Ternary System Pt/Sn/Nd: Insertion of Pt into the Structures of Sn/Nd Intermetallics Yields Structural Complexity and Wealth.

The understanding of structure and bonding in intermetallic phases still lags behind that of molecular compounds. For that reason, exploring intermetallic phases and identifying structural patterns and relationships are particularly important for closing this knowledge gap. In particular, here we report on the addition of increasing amounts of platinum to ∼2:1 mixtures of tin and neodymium, which yields eight ternary Pt/Sn/Nd compounds, four of which have not been reported before. Interestingly, except for PtSnNd (1), all observed ternary phases of the system can be derived from the binary compounds Sn2Nd and Sn5Nd2 by adding Pt to the composition(s), as they lie on or close to two lines: Sn2Nd-Pt (Pt0.21(1)Sn2Nd (2), PtSn2Nd (3), Pt1.33Sn2Nd (4), Pt2-xSn2+xNd (x = 0.27(3), 5), and Pt3Sn2Nd (6)) or Sn5Nd2-Pt (Pt1.5Sn5-xNd2 (x = 0.16(2), 7) and Pt3Sn5Nd2-x (x = 0.161(8), 8)). While the introduction of increasing amounts of Pt to the binaries Sn2Nd and Sn5Nd2 leads to stepwise changes in the coordination environment of Nd, Pt preserves its coordination over the entire system in the form of interpenetrating bipyramidal {PtSn5Nd5} clusters.

Binary Intermetallics in the 70 atom % R Region of Two R-Pd Systems (R = Tb and Er): Hidden, Obscured, or Nonexistent?

Although rare-earth-metal-transition-metal (R/T) phase diagrams have been explored extensively, our recent studies have uncovered new previously nonexistent binary intermetallics. These compounds belong to a narrow region between 70 and 71.4 atom % of the rare-earth metal but represent four different structure types. The binaries Tb7Pd3 and Er17Pd7 are compositionally approaching (less than 1 atom % difference) the previously reported R2.16Pd0.89 (R = Tb and Er), and apparently form by peritectoid transformation, thus, being hard to detect by fast cooling. Tb7Pd3 (1) crystallizes in the Th7Fe3 structure type (hP20, P63mc, a = 9.8846(4) Å, c = 6.2316(3) Å, Z = 2) while Er17Pd7 (2) belongs to the Pr17Co7 type being its second reported representative (cP96, P213, a = 13.365(2) Å, Z = 4). Er17Pd7 (2) is overlapping with the cubic F-centered Er2.11Pd0.89 (3b, Fd3̅m, a = 13.361(1) Å, Z = 32) with practically identical unit cell parameters but a significantly different structure. Electronic structure calculations confirm that heteroatomic R-T bonding strongly dominates in all structures; T-T bonding interactions are individually strong but do not play a significant role in the total bonding.

Ternary Polar Intermetallics within the Pt/Sn/R Systems (R = La-Sm): Stannides or Platinides?

Starting generally with a 4:6:3 molar ratio of Pt, Sn, and R (where R = La-Sm), with or without the application of a NaCl flux, seven ternary compounds were obtained as single crystals. The platinides Pt4Sn6R3 (R = La-Nd) crystallize with the Pt4Ge6Pr3 type of structure (oP52, Pnma, a = 27.6-27.8 Å, b = 4.59-4.64 Å, c = 9.33-9.40 Å). With R = Pr, Pt4Sn6Pr3-x (oP52, Pnma, a = 7.2863(3) Å, b = 4.4909(2) Å, c = 35.114(1) Å) is also obtained, which might be considered a high-temperature polymorph with disorder on the Sn- and Pr-sites. For R = Nd and Sm, a structurally related isostructural series with a slightly different composition Pt3Sn5R2-x (oP52, Cmc21, a = 4.50-4.51 Å, b = 26.14-26.30 Å, c ≈ 7.29 Å) has been observed, together with Pt7Sn9Sm5 (oS42, Amm2, a = 4.3289(5) Å, b = 28.798(4) Å, c = 7.2534(9) Å) under the same conditions. The latter exhibits the rare Zr5Pd9P7-type structure, linking polar intermetallics to metal phosphides, in accord with P7Pd9Zr5≡Pt7Sn9Sm5. All structures may be described in terms of either negative Pt/Sn networks encapsulating positive R atoms, or {PtSnx} clusters (x = 5, 6, or rarely 7) sharing vertices and edges with R in the second coordination sphere and with considerable heterometallic Pt-R bonding contributions.

Gold Polar Intermetallics: Structural Versatility through Exclusive Bonding Motifs.

The design of new materials with desired chemical and physical characteristics requires thorough understanding of the underlying composition-structure-property relationships and the experimental possibility of their modification through the controlled involvement of new components. From this point of view, intermetallic phases, a class of compounds formed by two or more metals, present an endless field of combinations that produce several chemical compound classes ranging from simple alloys to true ionic compounds. Polar intermetallics (PICs) belong to the class that is electronically situated in the middle, between Hume-Rothery phases and Zintl compounds and possessing e/a (valence electron per atom) values around 2. In contrast to the latter, where logical rules of formation and classification systems were developed decades ago, polar intermetallics remain a dark horse with a huge diversity of crystal structures but unclear mechanisms of their formation. Partial incorporation of structural and bonding features from both nonpolar and Zintl compounds is commonly observed here. A decent number of PICs can be described in terms of complex metallic alloys (CMAs) following the Hume-Rothery electron-counting schemes but exhibit electronic structure changes that cannot be explained by the latter. Our research is aimed at the discovery and synthesis of new polar intermetallic compounds, their structural characterization, and investigation of their properties in line with the analysis of the principles connecting all of these components. Understanding of the basic structural tendencies is one of the most anticipated outcomes of this analysis, and systematization of the available knowledge is the initial and most important step. In this Account, we focus on a well-represented but rather small section of PICs: ternary intermetallic compounds of gold with electropositive and post-transition metals of groups 12 to 15. The strong influence of relativistic effects in its chemical bonding results in special, frequently unique structural motifs, while at the same time gold participates in common structure types as an ordinary transition element. Enhanced bonding strength leads to the formation and stabilization of complex homo- and heteroatomic clusters and networks that are compositionally restricted to just a few options throughout the periodic table. Because it has the highest absolute electronegativity among metals, comparable to those of some halogens, gold usually plays the role of an anion, even being able to form true salts with the most electropositive metals. We discuss the occurrence of the structure types and show the place of gold intermetallics in the general picture. Among the structures considered are ones as common as AlB2 or BaAl4 types, in line with the recently discovered diamond-like homoatomic metal networks, formation of local fivefold symmetry, different types of tunneled structures, and more complex intergrown multicomponent structures.

From the Nonexistent Polar Intermetallic Pt3Pr4 via Pt2- xPr3 to Pt/Sn/Pr Ternaries.

Although the Pt-Pr phase diagram has been explored well, recent work on rare-earth metal cluster halides with endohedral transition metal atoms has provided a new binary intermetallic that is nonexistent in the known phase diagram: The binary Pt3Pr4 (1) crystallizes in a new structure type ( mP56, P21/ c, a = 12.353(2) Å, b = 7.4837(9) Å, c = 17.279(2) Å, ß = 118.003(7)°, Z = 8) with six crystallographically independent Pt as well as eight Pr positions. The subsequent detailed investigation has led to another previously unreported, binary phase with the Ga2Gd3 structure type, Pt2- xPr3 (2, tI80, I4/ mcm, a = 11.931(9) Å, c = 14.45(1) Å, Z = 16), that is practically overlapping with the rhombohedral Pt2Pr3 existing in the phase diagram. Application of different tin containing fluxes to reproduce the newly detected phases brought about two almost iso-compositional ternary compounds with Sn, Pt4Sn6Pr2.91 (3), and Pt4Sn6Pr3 (4), as well as Pt12Sn24Pr4.84 (5). 3 is a representative of the Pt4Ge6Ce3 type ( oP52, Pnma, a = 7.2863(3) Å, b = 4.4909(2) Å, c = 35.114(2) Å), while 4 represents a new variant of the prolific T4 E6 R3 family ( T = transition metal, E = main group (semi)metal, R = rare-earth metal; Pt4Sn6Pr3: oP52, Pnma, a = 27.623(1) Å, b = 4.5958(2) Å, c = 9.3499(5) Å). Pt12Sn24Pr5- x (5) crystallizes as a variant of the Ni8Sn16Gd3 type ( cI82, Im3̅, a = 12.274(1) Å, Z = 2). Electronic structure calculations provide hints on the origin of the structural changes ( pseudo-polymorphism) for Pt xPr3 with x = 1.97 and 2.00, respectively, and reveal that heteroatomic Pt-Pr bonding strongly dominates in both binaries while the addition of the reactive metal tin leads to dominating Pt-Sn bonding interactions in the ternaries; Pt-Pt bonding interactions are strong but represent a minority in the binaries and are not present at all in the ternaries.

Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.

AIMS: Intracoronary infusion of autologous nucleated bone marrow cells (BMCs) enhanced the recovery of left ventricular ejection fraction (LVEF) after ST-segment elevation myocardial infarction (STEMI) in the randomised-controlled, open-label BOOST trial. We reassessed the therapeutic potential of nucleated BMCs in the randomised placebo-controlled, double-blind BOOST-2 trial conducted in 10 centres in Germany and Norway. METHODS AND RESULTS: Using a multiple arm design, we investigated the dose-response relationship and explored whether γ-irradiation which eliminates the clonogenic potential of stem and progenitor cells has an impact on BMC efficacy. Between 9 March 2006 and 16 July 2013, 153 patients with large STEMI were randomly assigned to receive a single intracoronary infusion of placebo (control group), high-dose (hi)BMCs, low-dose (lo)BMCs, irradiated hiBMCs, or irradiated loBMCs 8.1 ± 2.6 days after percutaneous coronary intervention (PCI) in addition to guideline-recommended medical treatment. Change in LVEF from baseline (before cell infusion) to 6 months as determined by MRI was the primary endpoint. The trial is registered at Current Controlled Trials (ISRCTN17457407). Baseline LVEF was 45.0 ± 8.5% in the overall population. At 6 months, LVEF had increased by 3.3 percentage points in the control group and 4.3 percentage points in the hiBMC group. The estimated treatment effect was 1.0 percentage points (95% confidence interval, -2.6 to 4.7; P = 0.57). The treatment effect of loBMCs was 0.5 percentage points (-3.0 to 4.1; P = 0.76). Likewise, irradiated BMCs did not have significant treatment effects. BMC transfer was safe and not associated with adverse clinical events. CONCLUSION: The BOOST-2 trial does not support the use of nucleated BMCs in patients with STEMI and moderately reduced LVEF treated according to current standards of early PCI and drug therapy.

Spontaneous Assembly of an Organic-Inorganic Nucleic Acid Z-DNA Double-Helix Structure.

Herein, we report a hybrid polyoxometalate organic-inorganic compound, Na2 [(HGMP)2 Mo5 O15 ]⋅7 H2 O (1; where GMP=guanosine monophosphate), which spontaneously assembles into a structure with dimensions that are strikingly similar to those of the naturally occurring left-handed Z-form of DNA. The helical parameters in the crystal structure of the new compound, such as rise per turn and helical twist per dimer, are nearly identical to this DNA conformation, allowing a close comparison of the two structures. Solution circular dichroism studies show that compound 1 also forms extended secondary structures in solution. Gel electrophoresis studies demonstrate the formation of non-covalent adducts with natural plasmids. Thus we show a route by which simple hybrid inorganic-organic monomers, such as compound 1, can spontaneously assemble into a double helix without the need for a covalently connected linear sequence of nucleic acid base pairs.

Electron counting rules and electronic structure in tetrameric transition-metal (T)-centered rare-Earth (R) cluster complex halides (X).

Electron partition schemes are a beneficial means to systematize bonding networks and to identify structure-bonding relationships in polar intermetallics. One prolific class of polymetal networks with simple counterions is the broad family of transition-metal (T)-centered rare-earth metal (R) cluster halides (X), which can be isolated or condensed to oligomers and chains. While the electronic structures of R cluster monomers and chains encapsulating T atoms have been studied systematically, the band structures of oligomers, in particular, the most frequent Friauf-type {T(4)R(16)} tetramers, have been investigated to a lesser extent. Therefore, the band structures of prototypical compounds with {T(4)R(16)}-type tetramers, while maintaining different compositions, were analyzed employing density functional theory based methods. Furthermore, these theoretical examinations provide insight into the origin of the 15 electron rule, which is significant for this class of compounds and correlates with the closed-shell configurations for these structures. Additional research focused on the band structure of monoclinic {Ru(4)Gd(16)}Br(23), which is composed of rhomboid-shaped {Ru(4)Gd(16)} tetramers.

Nickel hexa-yttrium deca-iodide, [NiY6]I10.

Comproportionation reactions of yttrium triiodide, yttrium and nickel led to the formation of the compound [NiY6]I10, which is isostructural with the prototypical [RuY6]I10. In particular, [NiY6]I10 is composed of isolated nickel centered yttrium octa-hedra (site symmetry -1) that are further surrounded by iodide ligands to construct a three-dimensional cluster complex framework. Although this compound has been previously detected by powder X-ray diffraction techniques [Payne & Corbett (1990 ▶). Inorg. Chem. 29, 2246-2251], details of the crystal structure for triclinic [NiY6]I10 were not provided.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.

OBJECTIVE: In Spring 2011, an unprecedented outbreak of Shiga toxin-producing Escherichia coli serotype O104:H4-associated hemolytic uremic syndrome occurred in Northern Germany. The aim of this study was to describe the clinical characteristics, treatments, and outcomes of critically ill patients with Shiga toxin-producing E. coli-associated hemolytic uremic syndrome during this outbreak. DESIGN, SETTING, AND PATIENTS: Multicenter, retrospective, observational study of critically ill adult patients with Shiga toxin-producing E. coli-associated hemolytic uremic syndrome in six hospitals in Hamburg, Germany, between May 2011 and August 2011. MEASUREMENTS AND MAIN RESULTS: During the study period, 106 patients with Shiga toxin-producing E. coli-associated hemolytic uremic syndrome were admitted to eight ICUs. The median age was 40 years (range, 18-83) with a female:male ratio of 3:1. The median time from onset of clinical symptoms to hospital admission was 3 days and from hospital to ICU admission an additional 3 days. A total of 101 patients (95.3%) had acute renal failure and 78 (73.6%) required renal replacement therapy. Intubation and mechanical ventilation were required in 38 patients (35.8%) and noninvasive ventilation was required in 17 patients (16.0%). The median duration of invasive ventilation was 7 days (range, 1-32 days) and the median ICU stay was 10 days (range, 1-45 days). Fifty-one patients (48.1%) developed sepsis; of these 51 patients, 27 (25.4%) developed septic shock. Seventy patients (66.0%) developed severe neurological symptoms. Ninety-seven patients (91.5%) were treated with plasma exchange and 50 patients (47.2%) received eculizumab (monoclonal anti-C5 antibody). The mortality rate was 4.7%. Mild residual neurological symptoms were present in 21.7% of patients at ICU discharge, and no patient required renal replacement therapy 6 months after ICU admission. CONCLUSIONS: During the 2011 Shiga toxin-producing E. coli-associated hemolytic uremic syndrome outbreak in Germany, critical illness developed rapidly after hospital admission, often in young women. The infection was associated with severe neurological and renal symptoms, requiring mechanical ventilation and renal replacement therapy in a substantial proportion of patients. Overall, recovery was much better than expected.

Dihydro-nium tetra-chromate(VI), (H(3)O)(2)Cr(4)O(13).

The crystal structure of (H(3)O)(2)Cr(4)O(13) is isotypic with K(2)Cr(4)O(13). The finite tetra-chromate anion in the title structure consists of four vertex-sharing CrO(4) tetra-hedra and exhibits a typical zigzag arrangement. The crystal packing is stabilized by hydrogen bonds between these anions and hydro-nium cations. The two different hydro-nium cations are surrounded by nine O atoms of tetra-chromate anions, with O⋯O distances ranging between 2.866 (8) and 3.282 (7) Å.

Theobrominium perchlorate dibenzo-18-crown-6 3.25-hydrate.

The co-crystal, C7H9N4O2 (+)·ClO4 (-)·C20H24O6·3.25H2O, consists of theobrominium (3,7-di-methyl-2,6-dioxo-1H-purin-9-ium) cations, perchlorate anions and dibenzo-18-crown-6 and water mol-ecules. The crown ether is in a bent conformation, in which the planes of the aromatic rings subtend an angle of 63.7 (1)°. Inter-molecular O-H⋯O hydrogen bonding between the water mol-ecules and the O atoms of the cyclic ether delimit an empty space reminiscent of a hollow cage. The water mol-ecules are additionally linked to the cations by N-H⋯O hydrogen bonding. One of the positions of the water molecules is occupied only fractionally (25%) and is located outside this framework.

Identifying a structural preference in reduced rare-earth metal halides by combining experimental and computational techniques.

The structures of two new cubic {TnLa(3)}Br(3) (Tn = Ru, Ir; I4(1)32, Z = 8; Tn = Ru: a = 12.1247(16) Å, V = 1782.4(4) Å(3); Tn = Ir: a = 12.1738(19) Å, V = 1804.2(5) Å(3)) compounds belonging to a family of reduced rare-earth metal halides were determined by single-crystal X-ray diffraction. Interestingly, the isoelectronic compound {RuLa(3)}I(3) crystallizes in the monoclinic modification of the {TnR(3)}X(3) family, while {IrLa(3)}I(3) was found to be isomorphous with cubic {PtPr(3)}I(3). Using electronic structure calculations, a pseudogap was identified at the Fermi level of {IrLa(3)}Br(3) in the new cubic structure. Additionally, the structure attempts to optimize (chemical) bonding as determined through the crystal orbital Hamilton populations (COHP) curves. The Fermi level of the isostructural {RuLa(3)}Br(3) falls below the pseudogap, yet the cubic structure is still formed. In this context, a close inspection of the distinct bond frequencies reveals the subtleness of the structure determining factors.

Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.

BACKGROUND: Prevalence of patent foramen ovale (PFO) with detectable right-to-left shunt is higher in young adults with transient ischemic attack (TIA) and stroke compared to the general population. So far, published series included different occluder systems, various indications and regimens of postprocedural anticoagulation. In our experience, occluder systems may be associated with an increased prevalence of thrombus formation, which has also reported by other groups. The aim of the present study was to evaluate the follow-up results after implantation of the Amplatzer® occluder in patients with PFO using a consistent anticoagulation regimen. METHODS AND RESULTS: One-hundred and fourteen patients with PFO (60 men; age: 47 ± 13 years) and ≥1 thromboembolic event were included. Other causes for embolism were excluded. PFO-closure was successful in all patients. All patients were treated with aspirin (100 mg/day) and clopidogrel (75 mg/day) for 6 months. TEE was repeated at a mean of 10.3 months. Mean clinical follow-up period was 18 ± 9 months. After a mean of 10 months, no patient had either a significant residual shunt nor a suspected thrombus formation on the occluder. During follow-up, 5 patients suffered from neurological events (1 stroke, 2 TIAs, 2 epileptic seizures), though complete closure of the PFO was documented by TEE. One patient suffered from bleeding complications (upper GI-bleeding). CONCLUSION: Percutaneous closure of PFO in symptomatic patients by Amplatzer® occluder represents an effective therapy with a low incidence of peri-interventional complications and recurrent thromboembolism. Thrombus formations on the occluder system were not detected in this cohort.

Tetra-µ-acetato-bis-[(1,3-benzothia-zole)copper(II)](Cu-Cu).

The title compound, [Cu(2)(CH(3)CO(2))(4)(C(7)H(5)NS)(2)] or [(C(7)H(5)NS)Cu](2)(µ-O(2)CCH(3))(4), crystallizes with one mol-ecule per unit cell. The coordination number of copper is six with four basal O atoms, one axial N atom and one axial Cu atom. Four acetate ligands act as bidentate linker and connect two Cu atoms, with a crystallographic inversion center located at the mid-point of the Cu-Cu bond. The acetate ligands form slightly distorted square planes around each metal ion, while the copper ions are displaced by 0.2089 (4) Šfrom these planes towards the N atoms. Thus, the Cu-Cu distance is elongated to 2.6378 (7) Å, compared with the 2.2180 (7) Šdistance between the two basal planes. The angle between the basal plane and the Cu-N bond is 4.84 (6)°.

Na(3)DyCl(6).

Single crystals of the title compound, tris-odium hexa-chloridodysprosate, Na(3)DyCl(6), were obtained as a by-product of synthesis using dysprosium(III) chloride and sodium chloride among others. The monoclinic structure with its typical ß angle close to 90° [90.823 (4)°] is isotypic with the mineral cryolite (Na(3)AlF(6)) and the high-temperature structure of the Na(3)MCl(6) series, with M = Eu-Lu, Y and Sc. The isolated, almost perfect [DyCl(6)](3-) octa-hedra are inter-connected via two crystallographically different Na(+) cations: while one Na(+) resides on centres of symmetry (as well as Dy(3+)) and also builds almost perfect, isolated [NaCl(6)](5-) octa-hedra, the other Na(+) is surrounded by seven chloride anions forming a distorted [NaCl(7)](6-) trigonal prism with just one cap as close secondary contact.

Synthesis, structure, and density functional theory analysis of a scandium dinitrogen complex, [(C(5)Me(4)H)(2)Sc](2)(mu-eta(2):eta(2)-N(2)).

Investigation of the bis(tetramethylcyclopentadienyl) metallocene chemistry of scandium has revealed that the method involving reduction of trivalent salts with alkali metals used with lanthanides can also be applied to scandium to make a dinitrogen complex of the first member of the transition metal series. ScCl(3) reacts with 2 equiv of KC(5)Me(4)H to form (C(5)Me(4)H)(2)ScCl(THF), 1, which reacts with allylmagnesium chloride to make (C(5)Me(4)H)(2)Sc(eta(3)-C(3)H(5)), 2. Complex 2 reacts with [HNEt(3)][BPh(4)] to yield [(C(5)Me(4)H)(2)Sc][(mu-Ph)BPh(3)], 3, which has just one primary Sc-C(phenyl) contact connecting the tetraphenylborate anion and the metallocene cation. Treatment of 3 with KC(8) in THF under N(2) generates [(C(5)Me(4)H)(2)Sc](2)(mu-eta(2):eta(2)-N(2)), which has a coplanar arrangement of scandium and nitrogen atoms within a square planar array of tetramethylcyclopentadienyl rings. Density functional calculations explain the bonding that results in the 1.239(3) A N-N bond distance in the (N=N)(2-) moiety.

Contrasts in structural and bonding representations among polar intermetallic compounds. Strongly differentiated Hamilton populations for three related condensed cluster halides of the rare-earth elements.

The crystal and electronic structures of three related R(3)TnX(3) phases (R = rare-earth metal, Tn = transition metal, X = Cl, I) containing extended mixed-metal chains are compared and contrasted: (1) Pr(3)RuI(3) (P2(1)/m), (2) Gd(3)MnI(3) (P2(1)/m), and (3) Pr(3)RuCl(3) (Pnma). The structures all feature double chains built of pairs of condensed R(6)(Tn) octahedral chains encased by halogen atoms. Pr(3)RuI(3) (1) lacks significant Ru-Ru bonding, evidently because of packing restrictions imposed by the large closed-shell size of iodine. However, the vertex Pr2 atoms on the chain exhibit a marked electronic differentiation. These are strongly bound to the central Ru (and to four I), but very little to four neighboring Pr in the cluster according to bond populations, in contrast to Pr2-Pr "bond" distances that are very comparable to those elsewhere. In Gd(3)MnI(3) (2), the smaller metal atoms allow substantial distortions and Mn-Mn bonding. Pr(3)RuCl(3) (3), in contrast to the iodide (1), can be described in terms of a more tightly bound superstructure of (2) in which both substantial Ru-Ru bonding and an increased number of Pr-Cl contacts in very similar mixed-metal chains are favored by the smaller closed-shell contacts of chlorine. Local Spin Density Approximation (LSDA) Linearized Muffin-Tin Orbital (LMTO)-ASA calculations and Crystal Orbital Hamilton Population (COHP) analyses show that the customary structural descriptions in terms of condensed, Tn-stuffed, R-R bonded polyhedral frameworks are poor representations of the bonding in all. Hamilton bond populations (-ICOHP) for the polar mixed-metal R-Tn and the somewhat smaller R-X interactions account for 75-90% of the total populations in each of these phases, together with smaller contributions and variations for R-R and Tn-Tn interactions. The strength of such R-Tn contributions in polar intermetallics was first established or anticipated by Brewer. The rare-earth-metal atoms are significantly oxidized in these compounds.

Chains of face-sharing {ZPr6} octahedra with alternating endohedral iridium atoms and chloride ions in {(Ir,Cl)Pr6}Cl10.

The most impressive feature of the crystal structure of IrPr(6)Cl(11) is chains of face-sharing {Pr(6)} octahedra that encapsulate, alternatingly, iridium atoms and chloride ions, according to the formulation {(Ir,Cl)Pr(6)}Cl(10). An alternative description of the structure is the connection of isolated {IrPr(6)} clusters that are surrounded in a mixed {ZR(6)}X(i)(12)/{ZR(6)}X(i)(8) type by chlorido ligands with a rather complex connectivity, {IrPr(6)}(Cl(i-a-a)(4/3)Cl(a-i-a)(8/3)Cl(i-a)(6/2)Cl(a-i)(6/2))(e)(Cl(i-i)(2/2))(f), to a three-dimensional structure of tetragonally packed cluster-complex chains.